We are traveling the bottom of the channel. I think it starts to move up shortly. Adolescent and Pediatric fixed dose phase 3 trials start this month and next month. FDA approval submission early/mid next year. Billion-dollar drug if it can get some funding? This is my own opinion, and you should not take any of this as financial advice.
Comment
⋅
Curious what this would mean for the current producers of such meds like NYSE:JNJ, NYSE:PFE, NYSE:NVS? I'm assuming they would buy out Cingulate quickly before something like that dented their sales.